Study of AMDX-2011P as a Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic Proteinopathy
Clinical trial NCT05542576 · COMPLETED
Trial details
- NCT number
- NCT05542576
- Sponsor
- Amydis Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-24
- Primary completion
- 2023-03-15
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.